tiprankstipranks
Symrise AG (DE:SY1)
XETRA:SY1
Want to see DE:SY1 full AI Analyst Report?

Symrise (SY1) AI Stock Analysis

37 Followers

Top Page

DE:SY1

Symrise

(XETRA:SY1)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
€87.00
▲(12.69% Upside)
Action:Reiterated
Date:03/07/26
The score is primarily held back by 2025 profitability and growth weakening (lower margins and ROE, slightly negative revenue growth) and a mixed-to-weak technical picture (below key moving averages). These are partly offset by a generally stable financial base (consistent free cash flow and manageable leverage), but the high P/E and modest yield weigh on valuation support.
Positive Factors
Stable gross margins
High and stable gross margins indicate durable product economics and inherent pricing power in core aromas, flavors and ingredients. This supports long-term profitability even if operating costs fluctuate, allowing the company to maintain unit-level margins and margin recovery options.
Negative Factors
2025 profitability deterioration
Sharp margin and ROE declines materially weaken return generation and internal capital formation. If these trends persist, the firm will face reduced ability to reinvest, lower shareholder returns, and higher sensitivity to cost inflation or volume shocks, pressuring long-term competitiveness.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable gross margins
High and stable gross margins indicate durable product economics and inherent pricing power in core aromas, flavors and ingredients. This supports long-term profitability even if operating costs fluctuate, allowing the company to maintain unit-level margins and margin recovery options.
Read all positive factors

Symrise (SY1) vs. iShares MSCI Germany ETF (EWG)

Symrise Business Overview & Revenue Model

Company Description
Symrise AG is a German-based specialist in providing a comprehensive array of ingredients, encompassing fragrances, flavor compounds, active cosmetic components, and functional raw materials. Its operations are structured into two principal divisi...
How the Company Makes Money
Symrise makes money primarily by developing, manufacturing, and selling specialty ingredients and formulations to business customers (B2B), with revenue largely tied to long-term, repeat purchasing by consumer packaged goods and food companies. It...

Symrise Financial Statement Overview

Summary
Overall fundamentals are stable (steady gross margins in the high-30% range, consistent positive free cash flow, and manageable leverage), but 2025 showed clear deterioration: revenue turned slightly negative (-1.16%), net margin dropped (~5.1% vs ~9.6% in 2024), EBIT margin fell (~9.4% vs ~14.5%), and ROE cooled (~6.7% vs ~12.0%).
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
65
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.93B5.00B4.73B4.62B3.83B
Gross Profit1.85B1.96B1.69B1.70B1.48B
EBITDA907.87M1.04B841.49M780.50M806.40M
Net Income249.30M478.20M340.47M280.01M374.92M
Balance Sheet
Total Assets8.11B8.32B7.85B7.78B6.64B
Cash, Cash Equivalents and Short-Term Investments1.01B709.49M393.03M314.86M465.14M
Total Debt2.61B2.55B2.56B2.55B1.80B
Total Liabilities4.36B4.31B4.16B4.17B3.39B
Stockholders Equity3.72B3.98B3.63B3.55B3.19B
Cash Flow
Free Cash Flow521.05M667.49M449.31M109.94M347.40M
Operating Cash Flow717.82M894.91M719.51M360.11M521.56M
Investing Cash Flow-310.51M-291.51M-358.29M-984.84M-713.60M
Financing Cash Flow-78.31M-281.88M-264.22M481.52M-92.15M

Symrise Technical Analysis

Technical Analysis Sentiment
Positive
Last Price77.20
Price Trends
50DMA
76.10
Positive
100DMA
74.07
Positive
200DMA
73.12
Positive
Market Momentum
MACD
1.95
Negative
RSI
67.88
Neutral
STOCH
83.61
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:SY1, the sentiment is Positive. The current price of 77.2 is below the 20-day moving average (MA) of 79.74, above the 50-day MA of 76.10, and above the 200-day MA of 73.12, indicating a bullish trend. The MACD of 1.95 indicates Negative momentum. The RSI at 67.88 is Neutral, neither overbought nor oversold. The STOCH value of 83.61 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:SY1.

Symrise Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
€7.27B46.871.89%8.92%-9.37%-47.49%
63
Neutral
€7.95B34.805.27%4.30%-9.48%-56.88%
58
Neutral
€11.51B30.919.75%1.75%-1.39%-47.86%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
53
Neutral
€4.83B-8.91-20.12%3.75%
49
Neutral
€1.39B-2.10-17.77%0.59%-14.31%-386.04%
45
Neutral
€12.44B-17.74-10.04%-8.72%-140.66%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:SY1
Symrise
83.76
-11.31
-11.89%
DE:BNR
Brenntag AG
55.00
-0.76
-1.36%
DE:1COV
Covestro
59.90
0.20
0.34%
DE:EVK
Evonik
15.79
-1.30
-7.59%
DE:LXS
LANXESS
16.11
-7.99
-33.15%
DE:WCH
Wacker Chemie AG
97.60
37.70
62.94%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 07, 2026